Abstract:Purpose: Despite the efforts of countless researchers to develop glioma treatment strategies, the current therapeutic effect of glioma is still not ideal, and it is necessary to further explore the mechanism to guide treatment. Thus, this study aims to introduce a novel approach for predicting patient prognosis and guiding further treatment interventions. Methods: Initially, we conducted a differential gene expression analysis to identify Hippo pathway-associated genes overexpressed in tumors and determined genes correlated with prognosis. Subsequently, employing cluster analysis, we categorized samples into two groups and performed further analyses including prediction, immune cell infiltration abundance, and drug response rates. We utilized weighted gene co-expression analysis to reveal gene sets with high co-variation, delineate inter-sample gene correlation patterns, and conduct enrichment analysis. Prognostic models were built using ten machine learning algorithms combined in 101 different combinations, followed by evaluation and validation. Immune infiltration analysis, differential expression analysis of depleted T cell-related markers, drug sensitivity analysis, and exploration of pathway dysregulation were performed for different risk groups. Quality control and batch integration were performed, and single-cell data were analyzed using dimensionality reduction clustering algorithms and annotation tools to evaluate the activity of the prognostic model in malignant cells. Results: We conducted data filtering to identify genes overexpressed in tumors, intersecting these genes with Hippo pathway-related genes, identifying 62 genes correlated with prognosis, and performing cluster analysis to divide tumor tissues into two groups. Cluster 2 exhibited a poorer prognosis and demonstrated differences in immune cell infiltration. Utilizing weighted gene co-expression analysis on Cluster 2, we identified gene modules, conducted functional enrichment analysis, and delineated pathways. Employing a combined model based on ten machine learning algorithm combinations, we selected the optimal prognostic model system and validated the model's predictive ability within the dataset. Through immune-related analysis and drug sensitivity analysis, we uncovered differences in immune infiltration and varying sensitivities to chemotherapy drugs. Additionally, the enrichment analysis of gene set revealed discrepancies in upregulation within relevant pathways between the high and low-risk groups. Finally, annotation and evaluation of malignant cells via single-cell analysis showed increased activity of the prognostic model and variations in distribution across different prognostic levels in malignant cells. Conclusion: This study introduces a novel approach utilizing the Hippo pathway and associated genes for glioma prognosis research, demonstrating the potential and significance of this method in evaluating the outcome for patients with glioma. These findings hold substantial clinical significance in guiding therapy and predicting outcomes for individuals diagnosed with glioma, offering significant clinical utility.

Proteomics Reveals Protein Phosphatase 1 Gamma As A Biomarker Associated With Hippo Signal Pathway In Glioma

Analysis of the Expressions and Prognostic Significance of AJUBA and YAP1 in Glioma

Significant Role of PPP3CB in Malignant Gliomas Development, Prognosis and Potential Therapeutic Application—a Study Based on Comprehensive Bioinformatics, Cell Experiments and Immunohistochemistry Analyses

Expression and Significance of Hippo/YAP Signaling in Glioma Progression.

Expression Of Yap1 And Pstat3-S727 And Their Prognostic Value In Glioma

Analysis of the expression and prognostic value of MT1-MMP, β1-integrin and YAP1 in glioma

PMEPA1 Isoform a Drives Progression of Glioblastoma by Promoting Protein Degradation of the Hippo Pathway Kinase LATS1

Comprehensive analysis and molecular map of Hippo signaling pathway in lower grade glioma: the perspective toward immune microenvironment and prognosis

The Expression and Prognostic Value of ILK and YAP1 in Glioma.

Overexpression of ZEB1 and YAP1 is related to poor prognosis in patients with gliomas with different IDH1 status

Overexpression of Golgi Phosphoprotein-3 (GOLPH3) in Glioblastoma Multiforme is Associated with Worse Prognosis

Exploring the significance and potential mechanisms of hippo pathway-associated genes in prognosis of glioma patients

Identification of Secreted Phosphoprotein 1 (SPP1) As a Prognostic Factor in Lower-Grade Gliomas

Phytanoyl-CoA 2-Hydroxylase-Interacting Protein-Like Gene Is a Therapeutic Target Gene for Glioblastoma Multiforme

The Diagnostic Value and Functional Roles of Phosphoglycerate Mutase 1 in Glioma.

Research Progress on the Regulation Mechanism of Key Signal Pathways Affecting the Prognosis of Glioma

Novel Biomarker Genes for Prognosis of Survival and Treatment of Glioma

High myosin binding protein H expression predicts poor prognosis in glioma patients

Overexpression of GBP1 Predicts Poor Prognosis and Promotes Tumor Growth in Human Glioblastoma Multiforme.

Protein Phosphatase 1γ Regulates the Proliferation of Human Glioma Via the NF-κB Pathway

PCGF1 is a prognostic biomarker and correlates with tumor immunity in gliomas